garkaviy_eu2p_pv and pharmaepidemiology_intro to quantitative benefit-risk analyses methods

1
This is to certify that Pavlo Garkaviy has successfully passed the final examination with a score of 86.67% on September 27 th 2016 to be delivered the CERTIFICATE OF TRAINING ACHIEVEMENT IN PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLOGY INTRODUCTION TO QUANTITATIVE BENEFIT-RISK ANALYSES METHODS Having regard to the Eu2P Grant Agreement signed on February 11 th 2010, with the members of the European Programme of Pharmacovigilance and Pharmacoepidemiology consortium. Bordeaux, on September 27 th 2016 The Academic Coordinator on behalf of the Eu2P Education Board

Upload: pavel-garkaviy

Post on 11-Feb-2017

15 views

Category:

Documents


0 download

TRANSCRIPT

This is to certify that

Pavlo Garkaviyhas successfully passed the final examination with a score of 86.67%

on September 27th 2016 to be delivered the

CERTIFICATE OF TRAINING ACHIEVEMENTIN PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLOGY

INTRODUCTION TO QUANTITATIVE BENEFIT-RISK ANALYSESMETHODS

Having regard to the Eu2P Grant Agreement signed on February 11th 2010, with the members ofthe European Programme of Pharmacovigilance and Pharmacoepidemiology consortium.

Bordeaux, on September 27th 2016The Academic Coordinatoron behalf of the Eu2P Education Board